Breaking News Bar

Business News and Information

Regeneron officials sell $1M in stock after Trump calls COVID-19 treatment drugs 'miracles'

Securities and Exchange Commission filings show that two executives at Regeneron, a biotech company at the cutting edge of coronavirus treatment, netted about $1 million through sales of the company's stock after President Trump praised what he described as Regeneron's coronavirus "cure."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear